Summary. Uterine 
Introduction
In mice and many other species of mammals, implantation of the blastocyst can be delayed. In this condition, both embryonic and uterine preparation for implantation are suspended for a period of time. It is generally acknowledged that embryonic 'diapause' in the mouse is the result of the absence of oestrogen secretion during the luteal phase (Finn & Martin, 1974) . Final uterine sensitization for implantation and blastocyst activation is triggered by an increased secretion of oestrogen (Humphrey, 1969) . Blastocyst activation appears to be controlled by changes in the uterine environment (Aitken, 1977a, b) . The manner by which the uterine environment exerts these effects is at present not known. It has been proposed that the uterine environment may act by containing an inhibitor of blastocyst metabolism which is negated by the 'nidatory' oestrogen secre¬ tion, or that blastocyst activation may result from the production of activating substances which are absent during embryonic 'diapause' (McLaren, 1973; Psychoyos, 1973 (Weitlauf, 1976 (Weitlauf, , 1978 . Psychoyos & Casimiri ( 1981) have shown that rat and human uterine fluids, collected at periods refractory to implantation, are toxic to rat ova. Aitken (1977a, b) (Kirby, 1969) and oviduct (Weitlauf, 1971) result in blasto¬ cyst activation. Bitton-Casimiri, Brun & Psychoyos (1976) (Finn & Downie, 1975) and rats (Camus, Lejeune & Leroy, 1979) with experimentally 'delayed' blastocysts has added support for the role of putative intrauterine inhibitory factors of a protein nature. However, a widespread acceptance of the role of uterine inhibitory factors in embryonic 'diapause' has been prevented due to the inability to demonstrate the loss of the inhibitory influence of uterine flushings at the time of blastocyst activation (Weitlauf, 1976) .
In the experimental design used by Weitlauf (1976) Embryos. All mice used were of the F, hybrid cross (C57BL CBA, or reciprocal) and were exposed to light from 07 :30 to 21 :30 h. Blastocysts were collected from 3-6-week-old females which had been induced to superovulate by intraperitoneal injection of 5-10 i.u. PMSG (Folligon: Intervet, Boxmeer, Holland) given at 15 :00-17 :00 h, followed 46-50 h later by an injection of 5-10 i.u. hCG (Chorulon: Intervet). After the second injection, the females were placed with fertile males of the same F ! hybrid type and checked the following morning for copulation plugs ( = Day 1 of pregnancy). Blastocysts were recovered between 12 :00 and 15 :00 h on Day 4 of pregnancy. The medium used for collection and culture of blastocysts was that of Whitten (Medium W, ) prepared as indicated by Hoppe & Pitts (1973) .
Uterine fluids. Mature female mice were induced to ovulate by the administration of 5 i.u. PMSG and hCG as described above. The animals in Group A were not mated and were artificially 'pseudopregnant', those in Group were pseudopregnant after mating with a vasectomized male and those in Group C were impregnated by fertile males.
The three groups of animals were bilaterally ovariectomized on the equivalent of Day 3 of pregnancy. The animals were injected with progesterone (2 mg/0-1 ml peanut oil, s.c.) on Days 6 and 7. On Day 8, the mice were injected s.c. with 0-2 mg progesterone and 0-75 pg oestradiol-17ß to simulate the hormonal changes in delayed implantation (Days 6 and 7) followed by implantation (Day 8). Four mice from each treatment group were killed on Day 8 at 1, 2-5, 6-25 and 15-6 h after the progesterone and oestrogen injection.
A fourth group of animals (Group D) was induced to ovulate, mated with fertile males and bilaterally ovariectomized on Day 3. Embryonic 'diapause' was maintained up to Day 15 by a daily injection of 2 mg progesterone. Uterine fluid was collected from these animals on Days 6,9, 12 and 15 of pregnancy.
The uteri of all treated mice were removed and flushed with 50 µ cold (4°C) triple-distilled water, taking care not to introduce any contaminating fluid or cellular debris into the flushings, which were kept on ice during the collection period (Weitlauf, 1976) . The flushing procedure was carried out in less than 2 sec to minimize the effect of hypotonie shock to endometrial cells.
Fluid was pooled and centrifuged at 70 000 g for 1 h at 4°C. The supernatant was decanted and its protein concentration determined by the method of Lowry, Rosebrough, Farr & Randall (1951 (Zar, 1974 (Bergstrom & Nilsson, 1975) . The results give circumstantial support to the theory that the control of blastocyst activation in the mouse may be due to the presence of uterine inhibitors of embryonic metabolism during embryonic diapause which are negated at the time of blastocyst activation. The fact that the reduction of the inhibitory influence occurs in pregnant but not pseudopregnant mice, together with the evidence that blastocysts can neutralize the effect of the uterine inhibitor in vitro (O'Neill & Quinn, 1981) , suggests that the loss of the inhibitory effect in vivo is an embryo-dependent event. However, blastocysts are present in the uterus in normal and 'delayed' implantation, but diapausing blasto¬ cysts do not cause a loss of the inhibitory effect. This might be explained by one of two hypotheses.
(1) The blastocyst could continue to neutralize the inhibitory activity during diapause but the secre¬ tion continues at concentrations compatible with embryonic dormancy. Following 'nidatory' oestrogen the secretion of the inhibitor is halted or decreases to such an extent that the embryodependent negation of the inhibitor becomes dominant, resulting in an effective reduction in concentration. (2) The response of the blastocyst could be different during 'delayed' and normal implantation such that the embryo-dependent negation of the inhibitory effect occurs only after the 'nidatory' oestrogen surge. Our results do not indicate which of these possibilities, if either, is involved.
It is also unclear how the embryo causes this loss of inhibitory activity. The embryo could act directly on the uterine secretion or indirectly via the endometrium to alter the nature of the secre¬ tions. There may be a decrease in the concentration of specific inhibitory factors or a fall in the activity of the factors without a change in the concentration. Such a change in activity might be achieved by a mechanism of the type proposed by Weitlauf (1976) (Aitken, 1977c; Pratt, 1977; Surani, 1977; Fishel, 1979) ; (b) this profile of uterine secretion is significantly greater in pregnant mice compared with pseudopregnant mice (Aitken 1977d) , presumably representing an embryo-dependent event; and (c) blastocyst activation in vitro does not occur in simple defined medium but has a requirement for extracellular macromolecules (Fishel & Surani, 1978) . Nevertheless, blastocyst activation can be induced in animals undergoing delayed implantation by the injection of actinomycin D (Finn & Downie, 1975 ; Camus et al., 1979) which significantly effects the characteristic profile of uterine protein secretion. The embryodependent loss of the inhibitory activity also occurs in vitro (O'Neill & Quinn, 1981) which is a static system in which there is no increase in secretion of trophic factors. These arguments add support to the suggestion that the embryos act to cause a decrease in the activity of specific inhibitory factors. This does not rule out the possibility, however, that a concomitant rise in the activity of trophic factors may also occur.
As a working model, we propose that the uterine environment contains inhibitors of blastocyst metabolism throughout the preimplantation period of pregnancy and embryonic 'diapause'. Following the 'nidatory' oestrogen surge there is an embryo-dependent reduction of this inhibitory activity, allowing blastocyst activation to proceed. Blastocyst activation is likely to be promoted by one or more of the factors secreted into the uterine lumen.
